Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAL + Aktilite in Facial Photodamage
NCT00629317Phase 3Completed
- Sponsor
- Universidad de Antioquia
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of methyl aminolevulinate in facial photodamage, sponsored by Universidad de Antioquia. Started Feb 2008; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
facial photodamage
Beyond the preview
Go deeper on NCT00629317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629317.